E-LIB Suche - Ergebnisse für: Niggli, Markus

1

Pharmacokinetics and coagulation biomarkers in children and..:

Kiialainen, Anna ; Adamkewicz, Joanne I. ; Petry, Claire...
Research and Practice in Thrombosis and Haemostasis. 8 (2024) 1 - p. 102306 , 2024

Link: https://doi.org/10.1016/..

2

Emicizumab prophylaxis in infants with hemophilia A (HAVEN ..:

Pipe, Steven W. ; Collins, Peter ; Dhalluin, Christophe...
Blood. 143 (2024) 14 - p. 1355-1364 , 2024

Link: https://doi.org/10.1182/..

3

Long-term outcomes with emicizumab in hemophilia A without ..:

Mahlangu, Johnny ; Jiménez-Yuste, Víctor ; Ventriglia, Giuliana...
Research and Practice in Thrombosis and Haemostasis. 8 (2024) 2 - p. 102364 , 2024

Link: https://doi.org/10.1016/..

4

Effect of emicizumab prophylaxis on bone and joint health m..:

Kiialainen, Anna ; Niggli, Markus ; Kempton, Christine L....
Haemophilia. 28 (2022) 6 - p. 1033-1043 , 2022

Link: https://doi.org/10.1111/..

5

Surgical outcomes in people with hemophilia A taking emiciz..:

Kruse-Jarres, Rebecca ; Peyvandi, Flora ; Oldenburg, Johannes...
Blood Advances. 6 (2022) 24 - p. 6140-6150 , 2022

Link: https://doi.org/10.1182/..

6

Emicizumab dose up‐titration in case of suboptimal bleeding..:

Schmitt, Christophe ; Mancuso, Maria Elisa ; Chang, Tiffany...
Haemophilia. 29 (2022) 1 - p. 90-99 , 2022

Link: https://doi.org/10.1111/..

7

Development and testing of the Satisfaction Questionnaire w..:

Kempton, Christine ; Trask, Peter ; Parnes, Aric...
Haemophilia. 27 (2021) 2 - p. 221-228 , 2021

Link: https://doi.org/10.1111/..

8

Low immunogenicity of emicizumab in persons with haemophili..:

Schmitt, Christophe ; Emrich, Thomas ; Chebon, Sammy...
Haemophilia. 27 (2021) 6 - p. 984-992 , 2021

Link: https://doi.org/10.1111/..

9

The effect of emicizumab prophylaxis on long‐term, self‐rep..:

Skinner, Mark W. ; Négrier, Claude ; Paz‐Priel, Ido...
Haemophilia. 27 (2021) 5 - p. 854-865 , 2021

Link: https://doi.org/10.1111/..

10

Assessment of Drug–Drug Interactions between Taspoglutide, ..:

Bogman, Katrijn ; Brumm, Jochen ; Hofmann, Carsten...
Clinical Pharmacokinetics. 58 (2019) 9 - p. 1205-1214 , 2019

Link: https://doi.org/10.1007/..

11

Efficacy of emicizumab prophylaxis versus factor VIII proph..:

Reyes, Adriana ; Révil, Cédric ; Niggli, Markus...
Current Medical Research and Opinion. 35 (2019) 12 - p. 2079-2087 , 2019

Link: https://doi.org/10.1080/..

12

Effect of varying degrees of renal impairment on the pharma..:

Giraudon, Mylène ; Sturm, Stefan ; Lambert, Nathalie...
Diabetes, Obesity and Metabolism. 19 (2017) 4 - p. 537-544 , 2017

Link: https://doi.org/10.1111/..

13

A Bayesian combination method of flood models: Principles a..:

Niggli, Markus ; Musy, André
Agricultural Water Management. 77 (2005) 1-3 - p. 110-127 , 2005

Link: https://doi.org/10.1016/..

14

Emicizumab dose up‐titration in case of suboptimal bleeding..:

Schmitt, Christophe ; Mancuso, Maria Elisa ; Chang, Tiffany...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091821/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Surgical outcomes in people with hemophilia A taking emiciz..:

Kruse-Jarres, Rebecca ; Peyvandi, Flora ; Oldenburg, Johannes...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768240/. , 2022

Link: http://www.ncbi.nlm.nih...